Meta-analysis of 14 RCTs (3128 adults with chronic heart failure and anaemia): ESAs vs placebo or no treatment did not reduce first heart failure hospitalisation (OR 0.93, P=0.37) but reduced total HF hospitalisations (IRR 0.81); no difference in all-cause mortality.
Meta-analysisn = 3,128
Bunting et al. Erythropoiesis-stimulating agents to reduce heart failure hospitalization: a systematic review and meta-analysis